Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Quarterly Cashflow ⢠Improved Balance Sheet ⢠High Valuation Risk HNGE's strong quarterly profitability, cash flow, and liquidity mark a major turnaround, but high valuation, elevated costs, dilution, and large accumulated losses warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Modest monthly gain ⢠Volatile price swings ⢠Resistance test Support Level: $90.00â$90.50 Resistance Level: $92.85 HNGE is modestly bullish over the last month but faces key $92.85 resistance amid volatile swings, with $90.00â$90.50 support critical to preserving upside momentum.
Sentiment & News
Key News Insights: ⢠Strong Earnings ⢠Raised Outlook ⢠Care Expansion Hinge Health's strong earnings, raised outlook, and expansion into new care markets support bullish momentum, though elevated execution expectations and investment needs remain key risks.
AI Summary
HNGE's investment case has evolved into a premium-priced multi-specialty virtual-care platform, with strong MSK operating leverage now needing validation through accretive Cylinder integration and scalable GI/surgical expansion; investors should await evidence that margins and cash flow hold as growth broadens, since valuation leaves little room for execution misses.
Description
Hinge Health develops software for musculoskeletal care, providing digital programs and services that support treatment of acute injuries, chronic pain and post-operative rehabilitation. The company also offers administrative and operational support to health plans and employers. Founded in 2012, it is headquartered in San Francisco, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 17 | Jun 24 | HNGE | Hinge Health, Inc. | Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment. | Closed | +5.3% |
| May 14 | May 21 | HNGE | Hinge Health, Inc. | Healthcare momentum candidate with strong execution: Q1 revenue was $182M, up 47% YoY and ahead of expectations, margins improved, management raised full-year revenue guidance, and Q1 free cash flow was $41.6M. Stock is up about 25% over the last 21 trading days with only a modest pullback from its recent high. | Closed | +2.3% |